P. Damodara Kumaran, M.D. – FDA Inspection, Jan 24, 2025

Record Details

This FDA Inspection record concerns P. Damodara Kumaran, M.D., with an inspection on January 24, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: P. Damodara Kumaran, M.D.
Inspection Date: January 24, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Gene R. Gunn (Company Rep)

View Company Profile

ID · c2e7f0b3-084f-4555-9d4e-75215efc1621

Inspection Facts

Inspection number: 1259109
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore P. Damodara Kumaran, M.D.

FDA Inspection

P. Damodara Kumaran, M.D.January 24, 2025